[Principles and method of action of targeted therapies]
1Arbeitsgruppe Senologie der Klinischen Abteilung für Allgemeine Gynäkologie und Gynäkologische Onkologie, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien, Österreich. christian.singer@meduniwien.ac.at
Abstract:
Conventional cytotoxic therapy is usually characterized by low specificity and considerable side effects. Targeted therapy, by contrast, allows for a specific inhibition with an acceptable side effect profile. A prerequisite for the development of such a therapy, however, is the identification and characterization of the molecular mechanisms that lead to tumor growth. Antibody-based targeted therapies usually attack cell membrane-bound or extracellular proteins, while tyrosin kinase inhibitors usually act at intracellular domains of transmembranous proteins. Both strategies ultimately lead to an inhibition of the signal transduction cascade and thereby block increased cell proliferation, metastasis, or the production of new blood or lymph vessels.
Insights
Targeted cancer therapy offers specific inhibition with fewer side effects than conventional cytotoxic treatments. Identifying tumor growth mechanisms is key to developing effective targeted therapies like antibody treatments and kinase inhibitors.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Conventional cytotoxic chemotherapy exhibits low specificity and significant adverse effects.
- Targeted therapy presents a more specific approach with an improved side effect profile.
- Understanding tumor molecular mechanisms is crucial for developing targeted treatments.
Purpose of the Study:
- To highlight the advantages of targeted therapy over conventional cytotoxic therapy.
- To emphasize the importance of identifying molecular drivers of tumor growth.
- To outline the mechanisms of action for antibody-based and kinase inhibitor therapies.
Main Methods:
- Review of current targeted therapy strategies.
- Comparison of targeted therapy with conventional cytotoxic therapy.
- Explanation of molecular targets for different targeted therapies.
Main Results:
- Targeted therapies demonstrate higher specificity and better tolerability.
- Antibody-based therapies target extracellular or cell surface proteins.
- Tyrosine kinase inhibitors target intracellular domains of transmembrane proteins.
Conclusions:
- Targeted therapies, including antibody-based treatments and tyrosine kinase inhibitors, effectively inhibit tumor growth pathways.
- Successful targeted therapy relies on precise identification of molecular targets.
- These targeted strategies reduce cell proliferation, metastasis, and angiogenesis.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
01:24Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...